Artificial intelligence is moving from the lab bench into the operating room, promising to spot and classify brain tumors with a level of speed and precision that would have sounded like science ...

RAD 101 demonstrated significant tumor uptake and 92% concordance with MRI in a phase 2b trial, enhancing confidence in its diagnostic potential. The agent targets fatty acid synthase, aiding in ...

A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and immune ...

Real-world data shows a clear association between increased tumor size and mortality in brain cancer patients. Early diagnosis using Dxcover's PANAROMIC liquid biopsy platform can reduce mortality ...